A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment - Wikidata - wikimedia - TriplyDB

A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment

A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment

http://www.wikidata.org/entity/Q24618342

about

Magnetic techniques for the isolation and purification of proteins and peptides Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase Aptamers in Therapeutics MIPs and Aptamers for Recognition of Proteins in Biomimetic Sensing.Aptamers: A Feasible Technology in Cancer Immunotherapy Generating Cell Targeting Aptamers for Nanotheranostics Using Cell-SELEX Aptamers: A promising chemical antibody for cancer therapy In Vitro Selection of Cancer Cell-Specific Molecular Recognition Elements from Amino Acid Libraries Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing Nucleic acid aptamers: an emerging frontier in cancer therapy Targeted therapy using nanotechnology: focus on cancer Smart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapy From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors Binding of an RNA aptamer and a partial peptide of a prion protein: crucial importance of water entropy in molecular recognition Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis Aptamer-Drug Conjugates Influence of target concentration and background binding on in vitro selection of affinity reagents Targeted delivery of chemotherapy agents using a liver cancer-specific aptamer Identification, characterization and application of a G-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2 Development of a novel DNA aptamer ligand targeting to primary cultured tumor endothelial cells by a cell-based SELEX method Acousto-microfluidics for screening of ssDNA aptamer.Single-Stranded DNA Aptamers against Pathogens and Toxins: Identification and Biosensing Applications.DNA Aptamer Technology for Personalized Medicine.Aptamers and their biological applications Aptamers Selected by Cell-SELEX for Molecular Imaging.SELEX-derived aptamers of the duck hepatitis B virus RNA encapsidation signal distinguish critical and non-critical residues for productive initiation of reverse transcription.Deconvolution of a complex target using DNA aptamers.Generation of highly specific aptamers via micromagnetic selection The smart targeting of nanoparticles Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.Aptamers and the next generation of diagnostic reagents.A microarray-based method to perform nucleic acid selections.RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells.Biochemical and structural features of extracellular vesicle-binding RNA aptamers.Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers Aptamer-incorporated hydrogels for visual detection, controlled drug release, and targeted cancer therapy Recent developments in protein and cell-targeted aptamer selection and applications Aptamers from cell-based selection for bioanalytical applications Aptamers selected by cell-SELEX for application in cancer studies.

P2860

Q24802396-2DB7F330-C6C3-44E1-97AF-D5A66D376B98 Q24803451-E5F5F554-421C-45C0-B881-4739EE6527EA Q26738413-0E309158-3157-4F2A-B344-724661AC4D0D Q26738688-485FBA0C-2291-4BD5-9BE8-64E3D3973FB3 Q26740303-16E499B1-16E9-4A6F-A77D-9E20AE2391B5 Q26744825-D36805AD-E77E-477C-84E2-60D4ABFFCE21 Q26766832-8A02ADF0-FD15-4151-B375-72CAC3A96B97 Q26782129-463A6444-C8DD-41E2-A7A1-8A8B3D4F0F90 Q26799218-A2E53C5B-B1D5-4EA6-92E8-46DEFB520B75 Q26825644-61771F8A-D234-4AC6-889C-F6AE6EF8992B Q26849947-51AC63A7-6A13-4BB1-8270-2972D036F6D1 Q27023361-8C0C4E7A-EDCF-4298-B2BD-F76B17CF0FCC Q27025832-7041AFCA-F140-44E9-858B-33B62AB854F7 Q27326068-A2184FA7-5D2A-41EA-A7D0-A201AE680BB0 Q27683664-629BEB90-23C4-4022-A0F5-467579145DC7 Q28088349-94AE54DD-AC56-4E96-ADDD-33240E91B718 Q28468281-B870CEB4-3748-4F10-A6F2-881ABC149FD9 Q28482831-888DB30C-2A97-4C6A-8427-BE08B8893505 Q28482911-500942BC-96D6-499B-BFDC-20AE74F3D3A2 Q28484118-5910D497-3DB6-44B4-9933-97914AF2A9BA Q28485460-AF7FC94B-2C85-4781-9BE1-B1CC39C676EE Q30381725-A1703BFC-807E-4675-8C5D-7674211E5E8E Q30406535-8A42A14E-9BA2-4DEF-ACC4-00128A6D604F Q30412965-FA1DDD60-A995-4ECB-AFF3-0DB369DE99CF Q30470240-E7991ACE-59BB-435E-BF60-AE95EA89F0A4 Q31026416-3728FF44-C634-402D-A75E-3923B5666B0E Q33206025-63763A64-B5B7-4BBE-AD46-5E98DEE6BAEF Q33221136-A9D01B15-81B2-4580-8EFD-1453F9C74720 Q33456077-39A277EF-512D-419E-AC67-5C8B80BB3D4F Q33593665-02A18387-9885-4A43-BC1B-C5DFA02BE9E6 Q33598723-D04898C5-190E-4882-8705-2320492CC486 Q33615065-CAEA3E09-C9F6-4AE8-B3C9-E0B7991A66F5 Q33698306-C05E15EC-1E07-469D-9B5D-83735B950F4B Q33713013-76826331-6591-49D9-B2FB-868D7EA0F210 Q33742127-A30C548D-1944-4547-87C5-56B0829E2B2C Q33832781-4A02822E-95A9-4BDF-B5A7-E035AB315F38 Q33901924-394765A9-AE27-43CC-839B-C957FCB60076 Q33908491-49CA996C-C30B-416B-AD37-C17392C5263A Q33920514-F3247A77-6C53-4F7F-91E8-214135EF4F62 Q34006173-B61CE598-A9FC-4E95-B6A2-DDE5E0B9D20A

P2860

A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment

http://www.wikidata.org/entity/Q24618342

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

A tenascin-C aptamer identifie ...... ands by exponential enrichment

@ast

A tenascin-C aptamer identifie ...... ands by exponential enrichment

@en

A tenascin-C aptamer identifie ...... ands by exponential enrichment

@nl

type

label

A tenascin-C aptamer identifie ...... ands by exponential enrichment

@ast

A tenascin-C aptamer identifie ...... ands by exponential enrichment

@en

A tenascin-C aptamer identifie ...... ands by exponential enrichment

@nl

prefLabel

A tenascin-C aptamer identifie ...... ands by exponential enrichment

@ast

A tenascin-C aptamer identifie ...... ands by exponential enrichment

@en

A tenascin-C aptamer identifie ...... ands by exponential enrichment

@nl

P1433

Q24618342-FEF45FE2-C0DF-4009-9061-766D34EBC4FF

P1476

Q24618342-B6118900-360F-4754-BB10-5DF14D7A5B0F

P2093

Q24618342-06E101E0-5D54-485E-992B-71A08562517F

Q24618342-52EAF5E4-8039-4408-B35D-F3D2847A5E51

Q24618342-74077D3B-0F7F-4673-98D1-73D861CA210C

Q24618342-9D8879EB-1BB8-465D-BAC2-4B975E85ED55

Q24618342-BBABC92C-0438-4D6F-BB5B-6B16838E29E0

P2860

Q24618342-004694EF-61CB-492F-BB53-570AEF4FBA21

Q24618342-0B6EE5F1-88AE-47FB-BE3B-02A2EBD34D99

Q24618342-165A8A9B-35F4-45A4-A559-757FE4A2CA95

Q24618342-1BD71B82-796A-4CAC-B47E-3D3D1521505A

Q24618342-27328CB8-8C3D-405A-A426-203319E849A8

Q24618342-3198037A-C5EE-45D3-9D7B-ABA38871ABC1

Q24618342-322FFBA5-4A2E-43CD-93E5-A6DEF53A8CF3

Q24618342-33B95937-E55C-43A9-BE83-B48576FCAE0A

Q24618342-36A35503-1681-4BDD-84C9-37C930B0282F

Q24618342-4210A257-848D-491E-8F9A-F98EFD56E02F

P304

Q24618342-446F80A4-577E-473B-9DDC-DEEBC8978771

P31

Q24618342-8293F9FF-77E9-4E21-9383-5A2A7CC0D0D1

P3181

Q24618342-C8BFA663-4872-45C1-A7C0-ED8F05E646D2

P356

Q24618342-A6690178-3887-4537-8F90-AFF13817791D

P407

Q24618342-2D7BC41D-D518-48F0-9A72-DDC8B04BDB89

P433

Q24618342-39E65B9D-8D47-44BC-99A8-C0BD62E75EB6

P478

Q24618342-32855224-BC1F-4F08-B4C4-28C3928EC614

P577

Q24618342-C731DE38-59D8-43A7-A89A-77B8BFA47EFE

P5875

Q24618342-818749C0-EBB2-4996-8527-433FD89480F1

P698

Q24618342-940CBFB6-8EC9-4ABE-9FB2-C6BBD3D68009

P932

Q24618342-9A117CDD-A49E-4C28-A878-4D85FDFACCC9

P3181

P356

PNAS.2136683100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A tenascin-C aptamer identifie ...... ands by exponential enrichment

@en

P2093

Brian J Hicke

http://www.w3.org/2001/XMLSchema#string

Dion A Daniels

http://www.w3.org/2001/XMLSchema#string

Hang Chen

http://www.w3.org/2001/XMLSchema#string

Kristine M Swiderek

http://www.w3.org/2001/XMLSchema#string

Larry Gold

http://www.w3.org/2001/XMLSchema#string

P2860

Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5' noncoding region: identification by automated liquid chromatography-tandem mass spectrometry

Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein

Interlocking structural motifs mediate molecular discrimination by a theophylline-binding RNA

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

In vitro selection of RNA molecules that bind specific ligands

Human tenascin gene. Structure of the 5'-region, identification, and characterization of the transcription regulatory sequences

Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions

Human Tenascin Gene

By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

The mathematics of SELEX against complex targets.

P304

15416-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

668995

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.2136683100

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8959443

http://www.w3.org/2001/XMLSchema#string

P698

14676325

http://www.w3.org/2001/XMLSchema#string

P932

307582

http://www.w3.org/2001/XMLSchema#string